Positive effects in patients with refractory lupus nephritis were also seen in another study that reported a dramatic reduction of proteinuria, of urine erythrocytes, and anti-dsDNA antibodies after starting low-dose IL-2 therapy, with no flares during the second year of IL-2 maintenance therapy.[50]. Here, IL2 is linked to lupus nephritis.